MinervaX reveals financing to development group B streptococcus vaccine
15th December 2022 Uncategorised 0Plans include phase 3 clinical development of novel GBS vaccine and an efficacy evaluation More: MinervaX reveals financing to development group B streptococcus vaccine Source: News
read more